Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 4:24 pm Sale | 13G | AMAG PHARMACEUTICALS INC AMAG | Palo Alto Investors LP | 0 0% | -3,045,065 (Position Closed) | View |
| 2021-02-16 08:27 am Sale | 13G | AMAG PHARMACEUTICALS INC AMAG | Camber Capital Management LP | 0 0% | -4,390,000 (Position Closed) | View |
| 2021-02-10 3:19 pm Sale | 13G | AMAG PHARMACEUTICALS INC AMAG | RENAISSANCE TECHNOLOGIES LLC | 0 0% | -2,030,200 (Position Closed) | View |
| 2020-11-16 4:38 pm Sale | 13D | AMAG PHARMACEUTICALS INC AMAG | Caligan Partners LP | 0 0% | -3,519,287 (Position Closed) | View |
| 2020-10-13 06:08 am Purchase | 13D | AMAG PHARMACEUTICALS INC AMAG | Magnetar Financial LLC | 2,379,149 6.9% | 2,379,149 (New Position) | View |
| 2020-10-07 4:28 pm Sale | 13G | AMAG PHARMACEUTICALS INC AMAG | ARMISTICE CAPITAL LLC | 0 0% | -4,300,000 (Position Closed) | View |
| 2020-02-14 1:31 pm Sale | 13G | AMAG PHARMACEUTICALS INC AMAG | Palo Alto Investors LP | 3,045,065 8.98% | -336,132 (-9.94%) | View |
| 2020-02-14 12:18 pm Purchase | 13G | AMAG PHARMACEUTICALS INC AMAG | ARMISTICE CAPITAL LLC | 4,300,000 12.7% | 300,000 (+7.50%) | View |
| 2020-02-13 08:01 am Purchase | 13G | AMAG PHARMACEUTICALS INC AMAG | STATE STREET CORP STT | 2,714,099 8% | 129,453 (+5.01%) | View |
| 2020-02-12 10:45 am Purchase | 13G | AMAG PHARMACEUTICALS INC AMAG | RENAISSANCE TECHNOLOGIES LLC | 2,030,200 5.99% | 2,030,200 (New Position) | View |
| 2020-02-12 09:24 am Sale | 13G | AMAG PHARMACEUTICALS INC AMAG | VANGUARD GROUP INC | 2,827,229 8.33% | -695,955 (-19.75%) | View |
| 2020-02-04 11:53 am Purchase | 13G | AMAG PHARMACEUTICALS INC AMAG | BlackRock Inc. BLK | 5,571,440 16.4% | 97,969 (+1.79%) | View |
| 2020-01-31 12:05 pm Purchase | 13G | AMAG PHARMACEUTICALS INC AMAG | GOLDMAN SACHS GROUP INC GS | 2,054,131 6.1% | 2,054,131 (New Position) | View |
| 2019-10-15 09:51 am Unchanged | 13G | AMAG PHARMACEUTICALS INC AMAG | Camber Capital Management LP | 4,390,000 12.9% | 0 (Unchanged) | View |
| 2019-10-10 4:32 pm Purchase | 13D | AMAG PHARMACEUTICALS INC AMAG | Caligan Partners LP | 3,519,287 10.4% | 19,859 (+0.57%) | View |
| 2019-09-20 08:03 am Purchase | 13D | AMAG PHARMACEUTICALS INC AMAG | Camber Capital Management LP | 4,390,000 12.9% | 1,740,000 (+65.66%) | View |
| 2019-09-04 08:15 am Unchanged | 13D | AMAG PHARMACEUTICALS INC AMAG | Caligan Partners LP | 3,499,428 10.3% | 0 (Unchanged) | View |
| 2019-08-15 3:00 pm Purchase | 13D | AMAG PHARMACEUTICALS INC AMAG | Caligan Partners LP | 3,499,428 10.3% | 3,499,428 (New Position) | View |
| 2019-06-27 6:08 pm Purchase | 13G | AMAG PHARMACEUTICALS INC AMAG | ARMISTICE CAPITAL LLC | 4,000,000 11.8% | 655,000 (+19.58%) | View |
| 2019-05-20 5:05 pm Purchase | 13G | AMAG PHARMACEUTICALS INC AMAG | ARMISTICE CAPITAL LLC | 3,345,000 9.9% | 1,467,000 (+78.12%) | View |